IDBS Blog
Success Stories
Webinars
In The News
Press Releases
Customer Support Portal
Resource Centre
Brand PortalJustin Gazard, Global Pharmacology & ADME Business Partner for Research Business Technology at Pfizer, talks to us about how ActivityBase has helped the business assess their success better, improve internal communication and enabled them to efficiently internalize, analyze and share data.
Early adoption of IDBS’ bioprocess platform puts Lonza Biologics ahead. Proactive use of IDBS’ E-WorkBook Suite delivers continuous improvement across research, development and business operations. Since adopting E-WorkBook, Lonza has seen: Improved data quality, with errors prevented Optimized business and individual processes Context-rich research and development data, making it...
Leading French biotech uses IDBS’ ActivityBase to optimize HTS and HCS. Inventiva has seen a tenfold decrease in the time it takes to complete analysis work. A spin-off of Abbott, Inventiva is a French biotech company specializing in running and managing integrated drug discovery partnerships from target validation up...
Chugai futureproofs business through ‘user-buy-in’ adoption of E‑WorkBook. Introduction of E-WorkBook sees productivity gains of up to 30% for Chugai pharmacologists and reduces Chugai’s reliance on paper, improving operational efficiencies and reducing risk. Since adopting E-WorkBook, Chugai has seen: Productivity gains of between 20-30% for pharmacology scientists Productivity gains...
Biokit futureproofs diagnostics business and maximizes R&D spend through introduction of E‑WorkBook. Since adopting E-WorkBook, Biokit has seen: Scientists saved up to six hours a week using E-WorkBook Over 40 staff members now using E-WorkBook across Biokit’s R&D teams Administration time reduced significantly Lab managers save 4.5 hours per...